- Biktarvy is a pill containing the following three medicines: . bictegravir (an integrase inhibitor). TAF (tenofovir alafenamide; the safer formulation of ...
- In late August 2019, a pill called Dovato (containing dolutegravir + 3TC) was approved for the treatment of HIV in Canada and other high-income countries. The ...
- The dual-drug regimen dolutegravir + 3TC, sold in a pill called Dovato, has been approved in Canada and other high-income countries for the treatment of HIV ...
- The clinical trials for Dovato (a combination of dolutegravir and 3TC) for the initial treatment of HIV or for a change to a simpler regimen have found this ...
- The pharmaceutical company ViiV Healthcare has been the leader in developing potent dual-drug HIV regimens, such as the following: . Juluca – a pill ...
- Dolutegravir belongs to a class of anti-HIV drugs called integrase inhibitors. In Canada and other high-income countries, dolutegravir is sold in the following ...
- Doravirine is available as a pill and sold under the brand name Pifeltro. It belongs to the class of anti-HIV drugs called non-nukes (NNRTIs). Doravirine is ...
- Fostemsavir is a drug that has completed phase III clinical trials. It is intended for use by people who have strains of HIV that are resistant to many classes ...
- HIV-positive people who doctors described as “heavily treatment-experienced” were enrolled in a study on fostemsavir called Brighte. Most participants had ...
- ViiV Healthcare has built at least one manufacturing facility to make fostemsavir. The factory should have some supplies of fostemsavir available toward the end ...
- The widespread availability of potent HIV treatment (ART) in Canada and other high-income countries has largely transformed HIV infection into a chronic ...
- In the early 1980s, medical records indicated that a new syndrome had suddenly and simultaneously appeared mostly among gay and bisexual men in North America ...